This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.

INSULIN LISPRO 100 units/mL Versus HUMALOG® (insulin lispro) 100 units/mL

When transitioning from Humalog® (insulin lispro) 100 units/mL to insulin lispro 100 units/mL, no dose conversion is needed.

Detailed Information

Do not perform dose conversion when transitioning to the generic

  • IL-100 3-mL Pen from Humalog 3-mL Pen

  • IL-100 10-mL vial from Humalog 10-mL vial, or

  • IL-100 3-mL Junior Pen from Humalog 3-mL Junior Pen.

For example, if a patient is transitioning from 20 units of Humalog, the patient would administer 20 units of generic IL-100.

Generic versions are identical to branded versions in terms of

  • active ingredients

  • inactive ingredients

  • manufacturing, and  

  • 3-mL Pen or 10-mL vial packaging.

Generic versions have unique NDC numbers, labels, and package inserts.

Enclosed Prescribing Information

HUMALOG® (insulin lispro injection), for subcutaneous or intravenous use, Lilly

INSULIN LISPRO INJECTION, for subcutaneous or intravenous use, Lilly


Generic = authorized generic

Humalog = Humalog® (insulin lispro injection) 100 units/mL

IL-100 = insulin lispro injection 100 units/mL

Lilly = Eli Lilly and Company

NDC = National Drug Code

Pen = KwikPen®

Date of Last Review: March 03, 2020

Contact Lilly

Call Us

If you need information about a Lilly product or want to report an Adverse Event or Product Complaint, you may call us.

Available Mon - Fri, 9am - 7pm EST

Or you can

Chat with us

Chat with us

Submit a Request

Visit Us @LillyMedical